Intersecting transcriptomic landscapes of hypertension and kidney function in African American women

Malak Abbas1, Pamela Martin2, Merry L Lindsey2,3

  • 1National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland, United States.

Insights

This study identified 95 female-specific genes linked to hypertension and kidney disease in African American women. These findings highlight immune activation and metabolic changes, paving the way for precision medicine to address kidney health disparities.

Area of Science:

  • Genomics
  • Nephrology
  • Precision Medicine

Background:

  • Hypertension is a significant risk factor for chronic kidney disease (CKD).
  • African American women face disproportionately higher rates of hypertension and CKD, leading to kidney health disparities.
  • The biological mechanisms linking hypertension to kidney dysfunction, particularly in women, are not well understood.

Purpose of the Study:

  • To uncover shared molecular signatures associated with hypertension and kidney function in African American women using transcriptomic analysis.
  • To identify female-specific molecular profiles contributing to hypertension-related kidney disease.
  • To elucidate biological pathways involved in kidney decline in this demographic.

Main Methods:

  • Analysis of whole blood mRNA sequencing data from 344 African American women (discovery and validation cohorts) and 147 African American men.
  • Differential expression (DE) analyses to identify messenger RNAs (mRNAs) associated with hypertension and estimated glomerular filtration rate (eGFR).
  • Pathway enrichment analyses to link identified genes to biological mechanisms and comparative analyses to determine female-specific findings.

Main Results:

  • Identification of 95 female-specific genes associated with both hypertension and reduced eGFR.
  • Pathway enrichment analysis revealed significant involvement of fibrosis, inflammation, lipid metabolism, and endothelial dysfunction.
  • Specific immune genes, such as IL32 and TNFSF12, were implicated in amplifying inflammation and kidney injury.

Conclusions:

  • Transcriptomic analysis reveals unique molecular signatures in African American women linking hypertension to impaired kidney function.
  • Sex-specific pathways involving immune activation, cytoskeletal remodeling, and metabolic dysregulation are key contributors to renal decline.
  • Findings support the development of precision medicine strategies to address kidney health disparities in African American women.

Related Concept Videos

Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
91
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.1K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
60
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
89
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
3.2K
Neural Regulation of Blood Pressure01:18

Neural Regulation of Blood Pressure

The neural regulation of blood pressure involves intricate interactions between the autonomic nervous system (ANS) and cardiovascular system, ensuring adequate perfusion of tissues. This regulation primarily occurs through baroreceptor and chemoreceptor reflexes, involving both short-term and long-term mechanisms.
Baroreceptor Reflex
Baroreceptors, located in the carotid sinuses and aortic arch, detect changes in blood pressure. When blood pressure rises, these stretch-sensitive receptors...
3.5K